These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. Diffusion changes predict cognitive and functional outcome: the LADIS study. Jokinen H, Schmidt R, Ropele S, Fazekas F, Gouw AA, Barkhof F, Scheltens P, Madureira S, Verdelho A, Ferro JM, Wallin A, Poggesi A, Inzitari D, Pantoni L, Erkinjuntti T, LADIS Study Group. Ann Neurol; 2013 May; 73(5):576-83. PubMed ID: 23423951 [Abstract] [Full Text] [Related]
44. White Matter Hyperintensity-Associated Blood-Brain Barrier Disruption and Vascular Risk Factors. Gupta N, Simpkins AN, Hitomi E, Dias C, Leigh R, NIH Natural History of Stroke InvestigatorsNeuro Vascular Brain Imaging Unit, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland.. J Stroke Cerebrovasc Dis; 2018 Feb; 27(2):466-471. PubMed ID: 29100854 [Abstract] [Full Text] [Related]
45. MRI biomarkers of vascular damage and atrophy predicting mortality in a memory clinic population. Henneman WJ, Sluimer JD, Cordonnier C, Baak MM, Scheltens P, Barkhof F, van der Flier WM. Stroke; 2009 Feb; 40(2):492-8. PubMed ID: 19109551 [Abstract] [Full Text] [Related]
47. Low-grade inflammation, but not endothelial dysfunction, is associated with greater carotid stiffness in the elderly: the Hoorn Study. van Bussel BC, Henry RM, Schalkwijk CG, Dekker JM, Nijpels G, Stehouwer CD. J Hypertens; 2012 Apr; 30(4):744-52. PubMed ID: 22343535 [Abstract] [Full Text] [Related]
52. Associations of cognitive reserve and psychological resilience with cognitive functioning in subjects with cerebral white matter hyperintensities. Arola A, Laakso HM, Pitkänen J, Koikkalainen J, Lötjönen J, Korvenoja A, Erkinjuntti T, Melkas S, Jokinen H. Eur J Neurol; 2021 Aug; 28(8):2622-2630. PubMed ID: 33977580 [Abstract] [Full Text] [Related]
53. Cerebral white matter hyperintensities (WMH): an analysis of cerebrovascular risk factors in Lebanon. Gebeily S, Fares Y, Kordahi M, Khodeir P, Labaki G, Fazekas F. Int J Neurosci; 2014 Nov; 124(11):799-805. PubMed ID: 24433122 [Abstract] [Full Text] [Related]
54. Effects of medial temporal atrophy and white matter hyperintensities on the cognitive functions in patients with Alzheimer's disease. Shim YS, Youn YC, Na DL, Kim SY, Cheong HK, Moon SY, Park KW, Ku BD, Lee JY, Jeong JH, Kang H, Kim EJ, Lee JS, Go SM, Kim SH, Cha KR, Seo SW. Eur Neurol; 2011 Nov; 66(2):75-82. PubMed ID: 21778730 [Abstract] [Full Text] [Related]
56. The influence of vascular risk factors and white matter hyperintensities on the degree of cognitive impairment in Parkinson's disease. Sławek J, Wieczorek D, Derejko M, Dubaniewicz M, Brockhuis B, Sitek E, Wilczewska L, Roszmann A, Lass P. Neurol Neurochir Pol; 2008 Nov; 42(6):505-12. PubMed ID: 19235103 [Abstract] [Full Text] [Related]